Hoya have recently released an update on their successful myopia control spectacle lens MiyoSmart. Called MiyoSmart IQ, the new lens builds on the success of MiyoSmart.

The global rise in myopia, commonly referred to as short sight, continues. Projections indicate that nearly half of the world’s population could be affected by 2050.

Optometrists have shifted our focus from simply prescribing glasses and contact lenses to improve vision. Now we have new lens and contact lens technology which reduce the risk of progression.

Progression means the strength of the prescription gets stronger as vision continues to worsen. This progression causes the eye to grow., called axial elongation. Occuring mainly during childhood and teen years, this is the key driver of future vision-threatening pathology.

We have been dispensing these MiyoSmart lenses for some years. There is strong evidence, from a two-year randomised controlled trial (RCT) showing these lenses are more effective than traditionally dispensed single-focus lenses. More effective at what? Slowing the progression of shortsightedness, with its associated eye lengthening.

Glasses remain one of the most accessible and widely accepted approaches for young children, which is why these lenses were revolutionary. The first study, and its follow up, showed a sustained treatment effect. So myopia did not progress.

These novel lenses have small dimples across, them, which are called DIMS - defocus incorporated multiple segments. The DIMS zone is in the periphery of the lens which is clear in the centre. The newer design has extended the zone and the intenisty of these DIMS.

Ask us for more information about myopia control and management.